Epilepsia · 1998 · 109 citations · 16 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyEpilepsyNeuropharmacologyAdult EpilepsyAntiepileptic PharmacologyAntiepileptic PharmacotherapyDrug-resistant EpilepsyGeneralized EpilepsySeizure DisordersAntiepileptic Clinical TrialsClonic SeizuresLamotrigine TreatmentSeizuresTreatment PeriodsTreatment-resistant EpilepsyTreatment-resistant SeizuresWashout Periods
PURPOSE: Lamotrigine (LTG) is recognised as effective add-on therapy for focal epilepsies, but this is the first double-blind, placebo-controlled, crossover study in treatment-resistant generalised epilepsy. METHODS: The study consisted of 2 x 8-week treatment periods followed by a 4-week washout period. Patients received doses of either 75 or 150 mg daily, depending on their concomitant antiepileptic drugs (AEDs). Long-term continuation was offered at the end of the study with open-label LTG. RESULTS: Five centres in Australia recruited 26 patients who were having absence, myoclonic, or generalized tonic-clonic seizures or a combination of these. Twenty-two patients completed the study. There was a significant reduction in frequency of both tonic-clonic and absence seizure types with LTG. A 350% decrease in seizures was observed for tonic-clonic seizures in 50% of cases and for absence seizures in 33% of evaluable cases. Rash was the only adverse effect causing discontinuation. Twenty-three of 26 opted for open-label LTG, with 20 still receiving LTG for a mean of 26 months. In these 20, 80% had > or =50% seizure reduction and five (25%) were seizure free. CONCLUSIONS: This study shows that LTG is effective add-on therapy in patients with refractory generalised epilepsies. Statistically significant reduction in seizures in both absence and tonic-clonic seizure types was seen even with low doses of LTG.
16
Proposal for Revised Classification of Epilepsies and Epileptic Syndromes
Epilepsia · 1989 · 5.4K citations
Medicine, Neurology, Neuroscience +12
Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy
David F. Smith, Gus A. Baker, Gary Davies et al. · Epilepsia · 1993 · 333 citations